Stockholders’ Equity (Details) - Schedule of nonvested performance-based units activity - Executive Officer [Member] - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Oct. 15, 2019 |
Oct. 19, 2020 |
|
| Performance share 1 [Member] | ||
| Stockholders’ Equity (Details) - Schedule of nonvested performance-based units activity [Line Items] | ||
| Total Grant | 80,500 | |
| Forfeitures | (14,500) | |
| Outstanding | 66,000 | |
| Fair Market Value At Grant Date (in Dollars) | $ 222 | |
| Performance share 2 [Member] | ||
| Stockholders’ Equity (Details) - Schedule of nonvested performance-based units activity [Line Items] | ||
| Total Grant | 98,600 | |
| Forfeitures | ||
| Outstanding | 98,600 | |
| Fair Market Value At Grant Date (in Dollars) | $ 207 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|